Literature DB >> 12917636

MDM2-ARF complex regulates p53 sumoylation.

Lihong Chen1, Jiandong Chen.   

Abstract

The p53 tumor suppressor is regulated by MDM2-mediated ubiquitination and degradation. Ubiquitination of p53 is regulated by ARF, which binds to MDM2 and inhibits its E3 ligase function. P53 is also subjected to modification by conjugation of SUMO-1. We found that a p53 mutant deficient for MDM2 binding (p53(14Q19S)) is poorly sumoylated in vivo compared to wild-type p53. Overexpression of MDM2 increases the level of p53 sumoylation, which is further stimulated by expression of ARF. Stimulation of p53 sumoylation requires a highly conserved region (102-116) encoded by exon 2 of ARF and correlates with the ability of ARF to target p53 to the nucleolus. An MDM2 deletion mutant (MDM2(Delta222-437)) with activated cryptic nucleolar localization signal also targets p53 to the nucleolus and efficiently promotes p53 sumoylation in the absence of ARF. Direct targeting of p53 to the nucleolus enhances its sumoylation in an MDM2- and ARF-dependent fashion. These results show that p53 sumoylation is regulated by MDM2- and ARF-mediated nucleolar targeting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917636     DOI: 10.1038/sj.onc.1206851

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  42 in total

Review 1.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

2.  Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.

Authors:  Stergios J Moschos; Yin-Yuan Mo
Journal:  J Mol Histol       Date:  2006-06-07       Impact factor: 2.611

3.  MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.

Authors:  Chuangui Wang; Alexey Ivanov; Lihong Chen; William J Fredericks; Ed Seto; Frank J Rauscher; Jiandong Chen
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

Review 4.  Ubiquitin and ubiquitin-like modifications of the p53 family.

Authors:  Ian R Watson; Meredith S Irwin
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

5.  SUMO E3 ligase activity of TRIM proteins.

Authors:  Y Chu; X Yang
Journal:  Oncogene       Date:  2010-10-25       Impact factor: 9.867

6.  SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress.

Authors:  Yonghua Yang; Wei Fu; Jiandong Chen; Nancy Olashaw; Xiaohong Zhang; Santo V Nicosia; Kapil Bhalla; Wenlong Bai
Journal:  Nat Cell Biol       Date:  2007-10-14       Impact factor: 28.824

7.  Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.

Authors:  Abhik Saha; Masanao Murakami; Pankaj Kumar; Bharat Bajaj; Karen Sims; Erle S Robertson
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

8.  SUMOylation of p53 mediates interferon activities.

Authors:  Laura Marcos-Villar; José V Pérez-Girón; Jéssica M Vilas; Atenea Soto; Carlos F de la Cruz-Hererra; Valerie Lang; Manuel Collado; Anxo Vidal; Manuel S Rodríguez; César Muñoz-Fontela; Carmen Rivas
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

9.  PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.

Authors:  Lisa Ivanschitz; Yuki Takahashi; Florence Jollivet; Olivier Ayrault; Morgane Le Bras; Hugues de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

10.  PTEN regulation by Akt-EGR1-ARF-PTEN axis.

Authors:  Jianxiu Yu; Sharon S Zhang; Kan Saito; Scott Williams; Yutaka Arimura; Yuliang Ma; Yuehai Ke; Veronique Baron; Dan Mercola; Gen-Sheng Feng; Eileen Adamson; Tomas Mustelin
Journal:  EMBO J       Date:  2008-12-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.